Kawasaki disease: diagnosis, management and cardiac sequelae

References

• Kawasaki T. [Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children]. Arerugi16(3), 178–222 (1967).
   PubMedGoogle Scholar
• Ayusawa M, Sonobe T, Uemura S et al. Revision of diagnostic guidelines for Kawasaki disease (the 5th revised edition). Pediatr. Int.47(2), 232–234 (2005).
   PubMed Web of Science ®Google Scholar
• Shulman ST, De Inocencio J, Hirsch R. Kawasaki disease. Pediatr. Clin. North Am.42(5), 1205–1222 (1995).
   PubMed Web of Science ®Google Scholar
• Burns JC, Kushner HI, Bastian JF et al. Kawasaki disease: a brief history. Pediatrics106(2), E27 (2000).
   Google Scholar
• Levin M, Tizard EJ, Dillon MJ. Kawasaki disease: recent advances. Arch. Dis. Child66(12), 1369–1372 (1991).
   PubMed Web of Science ®Google Scholar
• Nakamura Y, Yanagawa H, Ojima T, Kawasaki T, Kato H. Cardiac sequelae of Kawasaki disease among recurrent cases. Arch. Dis. Child.78(2), 163–165 (1998).
   PubMed Web of Science ®Google Scholar
• Cimaz R, Falcini F. An update on Kawasaki disease. Autoimmun. Rev.2(5), 258–263 (2003).
   PubMed Web of Science ®Google Scholar
• Fujita Y, Nakamura Y, Sakata K et al. Kawasaki disease in families. Pediatrics84(4), 666–669 (1989).
   PubMed Web of Science ®Google Scholar
• Nishimura S, Zaitsu M, Hara M et al. A polymorphism in the promoter of the CD14 gene (CD14/-159) is associated with the development of coronary artery lesions in patients with Kawasaki disease. J. Pediatr.143(3), 357–362 (2003).
   PubMed Web of Science ®Google Scholar
• Brogan PA, Shah V, Bagga A, Klein N, Dillon MJ. T cell Vβ repertoires in childhood vasculitides. Clin. Exp. Immunol.131(3), 517–527 (2003).
   PubMed Web of Science ®Google Scholar
• Han RK, Sinclair B, Newman A et al. Recognition and management of Kawasaki disease. CMAJ162(6), 807–812 (2000).
   PubMed Web of Science ®Google Scholar
• Burgner D, Harnden A. Kawasaki disease: What is the epidemiology telling us about the etiology? Int. J. Infect. Dis.9(4), 185–194 (2005).
   PubMed Web of Science ®Google Scholar
• Esper F, Shapiro ED, Weibel C et al. Association between a novel human coronavirus and Kawasaki disease. J. Infect. Dis.191(4), 499–502 (2005).
   PubMed Web of Science ®Google Scholar
• Gupta-Malhotra M, Rao PS. Current perspectives on Kawasaki disease. Indian J. Pediatr.72(7), 621–629 (2005).
   PubMedGoogle Scholar
• Belay ED, Erdman DD, Anderson LJ et al. Kawasaki disease and human coronavirus. J. Infect. Dis.192(2), 352–353; author reply 353 (2005).
   PubMed Web of Science ®Google Scholar
• Ebihara T, Endo R, Ma X, Ishiguro N, Kikuta H. Lack of association between New Haven coronavirus and Kawasaki disease. J. Infect. Dis.192(2), 351–352; author reply 353 (2005).
   PubMed Web of Science ®Google Scholar
• Brogan PA, Bose A, Burgner D et al. Kawasaki disease: an evidence based approach to diagnosis, treatment, and proposals for future research. Arch. Dis. Child86(4), 286–290 (2002).
   PubMed Web of Science ®Google Scholar
• Tizard JE. Recognition and management of Kawasaki disease. Curr. Paediatr.8, 97–101 (1999).
   Google Scholar
• Burns JC, Mason WH, Glode MP et al. Clinical and epidemiologic characteristics of patients referred for evaluation of possible Kawasaki disease. United States Multicenter Kawasaki Disease Study Group. J. Pediatr.118(5), 680–686 (1991).
   PubMed Web of Science ®Google Scholar
• Sundel RP. Update on the treatment of Kawasaki disease in childhood. Curr. Rheumatol. Rep.4(6), 474–482 (2002).
   PubMedGoogle Scholar
• Lee KY, Han JW, Hong JH et al. Inflammatory processes in Kawasaki disease reach their peak at the sixth day of fever onset: laboratory profiles according to duration of fever. J. Korean Med. Sci.19(4), 501–504 (2004).
   PubMed Web of Science ®Google Scholar
• Lin MT, Tsao LY, Cheng ML et al. Absence of hypercoagulability in acute Kawasaki disease. Pediatr. Int.47(2), 126–131 (2005).
   PubMed Web of Science ®Google Scholar
• Newburger JW, Takahashi M, Gerber MA et al. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Pediatrics114(6), 1708–1733 (2004).
   PubMed Web of Science ®Google Scholar
• Fukushige J, Takahashi N, Ueda Y, Ueda K. Incidence and clinical features of incomplete Kawasaki disease. Acta Paediatr.83(10), 1057–1060 (1994).
   PubMed Web of Science ®Google Scholar
• Joffe A, Kabani A, Jadavji T. Atypical and complicated Kawasaki disease in infants. Do we need criteria? West J. Med.162(4), 322–327 (1995).
   PubMedGoogle Scholar
• Terai M, Shulman ST. Prevalence of coronary artery abnormalities in Kawasaki disease is highly dependent on γ globulin dose but independent of salicylate dose. J. Pediatr.131(6), 888–893 (1997).
   PubMed Web of Science ®Google Scholar
• Durongpisitkul K, Gururaj VJ, Park JM, Martin CF. The prevention of coronary artery aneurysm in Kawasaki disease: a meta-analysis on the efficacy of aspirin and immunoglobulin treatment. Pediatrics96(6), 1057–1061 (1995).
   PubMed Web of Science ®Google Scholar
• Freeman AF, Shulman ST. Recent developments in Kawasaki disease. Curr. Opin. Infect. Dis.14(3), 357–361 (2001).
   PubMed Web of Science ®Google Scholar
• Gedalia A. Kawasaki disease: an update. Curr. Rheumatol. Rep.4(1), 25–29 (2002).
   PubMedGoogle Scholar
• Hashino K, Ishii M, Iemura M, Akagi T, Kato H. Re-treatment for immune globulin-resistant Kawasaki disease: a comparative study of additional immune globulin and steroid pulse therapy. Pediatr. Int.43(3), 211–217 (2001).
   PubMed Web of Science ®Google Scholar
• Newburger JW. Treatment of Kawasaki disease: corticosteroids revisited. J. Pediatr.135(4), 411–413 (1999).
   PubMed Web of Science ®Google Scholar
• Lee MS, An SY, Jang GC, Kim DS. A case of intravenous immunoglobulin-resistant Kawasaki disease treated with methotrexate. Yonsei Med. J.43(4), 527–532 (2002).
   PubMed Web of Science ®Google Scholar
• Thomas-Golbanov C, Sridharan S. Novel therapies in vasculitis. Expert Opin. Investig. Drugs10(7), 1279–1289 (2001).
   PubMed Web of Science ®Google Scholar
• Etheridge SP, Tani LY, Minich LL, Revenaugh JR. Platelet glycoprotein IIb/IIIa receptor blockade therapy for large coronary aneurysms and thrombi in Kawasaki disease. Cathet. Cardiovasc. Diagn.45(3), 264–268 (1998).
   PubMedGoogle Scholar
• Williams RV, Wilke VM, Tani LY, Minich LL. Does abciximab enhance regression of coronary aneurysms resulting from Kawasaki disease? Pediatrics109(1), E4 (2002).
   PubMed Web of Science ®Google Scholar
• Imagawa T, Mori M, Miyamae T et al. Plasma exchange for refractory Kawasaki disease. Eur. J. Pediatr.163(4–5), 263–264 (2004).
   PubMed Web of Science ®Google Scholar
• Ahn SY, Jang GC, Shin JS, Shin KM, Kim DS. Tumor necrosis factor-α levels and promoter polymorphism in patients with Kawasaki disease in Korea. Yonsei Med. J.44(6), 1021–1026 (2003).
   PubMed Web of Science ®Google Scholar
• Bacon PA. Endothelial cell dysfunction in systemic vasculitis: new developments and therapeutic prospects. Curr. Opin. Rheumatol.17(1), 49–55 (2005).
   PubMed Web of Science ®Google Scholar
• Carlton-Conway D, Ahluwalia R, Henry L et al. Behaviour sequelae following acute Kawasaki disease. BMC Pediatr.5(1), 14 (2005).
   PubMedGoogle Scholar
• Hirose K, Nakamura Y, Yanagawa H. Cardiac sequelae of Kawasaki disease in Japan over 10 years. Acta Paediatr. Jpn37(6), 667–671 (1995).
   PubMedGoogle Scholar
• Lu CP, Lee WJ, Ho MM, Hwang KC. Risk factors of coronary arterial aneurysm in Kawasaki disease. Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi34(3), 173–180 (1993).
   PubMedGoogle Scholar
• Honkanen VE, McCrindle BW, Laxer RM et al. Clinical relevance of the risk factors for coronary artery inflammation in Kawasaki disease. Pediatr. Cardiol.24(2), 122–126 (2003).
   PubMed Web of Science ®Google Scholar
• Zhang T, Yanagawa H, Oki I, Nakamura Y. Factors relating to the cardiac sequelae of Kawasaki disease one month after initial onset. Acta Paediatr.91(5), 517–520 (2002).
   PubMed Web of Science ®Google Scholar
• Tulloh RM, Wood LE. Coronary artery changes in patients with Kawasaki disease. Acta Paediatr. Suppl.93(446), 75–79 (2004).
   PubMedGoogle Scholar
• Suzuki A, Miyagawa-Tomita S, Komatsu K et al. Immunohistochemical study of apparently intact coronary artery in a child after Kawasaki disease. Pediatr. Int.46(5), 590–596 (2004).
   PubMed Web of Science ®Google Scholar
• Wilson N, Heaton P, Calder L et al. Kawasaki disease with severe cardiac sequelae: lessons from recent New Zealand experience. J. Paediatr. Child Health.40(9–10), 524–529 (2004).
   PubMed Web of Science ®Google Scholar
• Nakamura Y, Oki I, Tanihara S, Ojima T, Yanagawa H. Cardiac sequelae in recurrent cases of Kawasaki disease: a comparison between the initial episode of the disease and a recurrence in the same patients. Pediatrics102(6), E66 (1998).
   PubMed Web of Science ®Google Scholar
• Nakamura Y, Yashiro M, Oki I et al. Giant coronary aneurysms due to Kawasaki disease: a case-control study. Pediatr. Int.44(3), 254–258 (2002).
   PubMed Web of Science ®Google Scholar
• Fukushige J, Takahashi N, Ueda K et al. Long-term outcome of coronary abnormalities in patients after Kawasaki disease. Pediatr. Cardiol.17(2), 71–76 (1996).
   PubMed Web of Science ®Google Scholar
• Vanlieferinghen PH, Brunet F, Beaufrere AM, Borderon C, Dechelotte P. [Sudden unexpected death in an infant due to a ruptured coronary aneurysm revealing Kawasaki disease]. Arch. Pediatr.9(12), 1248–1251 (2002).
   PubMed Web of Science ®Google Scholar
• Hunsaker DM, Hunsaker JC 3rd, Adams KC, Noonan JA, Ackermann DM. Fatal Kawasaki disease due to coronary aneurysm rupture with massive cardiac tamponade. J. Ky. Med. Assoc.101(6), 233–238 (2003).
   PubMedGoogle Scholar
• Takahashi K, Oharaseki T, Naoe S, Wakayama M, Yokouchi Y. Neutrophilic involvement in the damage to coronary arteries in acute stage of Kawasaki disease. Pediatr. Int.47(3), 305–310 (2005).
   PubMed Web of Science ®Google Scholar
• Terai M, Yasukawa K, Honda T et al. Peripheral blood eosinophilia and eosinophil accumulation in coronary microvessels in acute Kawasaki disease. Pediatr. Infect. Dis. J.21(8), 777–781 (2002).
   PubMed Web of Science ®Google Scholar
• Samada K, Igarashi H, Shiraishi H, Hatake K, Momoi MY. Increased serum granulocyte colony-stimulating factor correlates with coronary artery dilatation in Kawasaki disease. Eur. J. Pediatr.161(10), 538–541 (2002).
   PubMed Web of Science ®Google Scholar
• Gavin PJ, Crawford SE, Shulman ST, Garcia FL, Rowley AH. Systemic arterial expression of matrix metalloproteinases 2 and 9 in acute Kawasaki disease. Arterioscler. Thromb. Vasc. Biol.23(4), 576–581 (2003).
   PubMed Web of Science ®Google Scholar
• Rowley AH. The etiology of Kawasaki disease: superantigen or conventional antigen? Pediatr. Infect. Dis. J.18(1), 69–70 (1999).
   PubMed Web of Science ®Google Scholar
• Ohmochi Y, Onouchi Z, Oda Y, Hamaoka K. Assessment of effects of intravenous dipyridamole on regional myocardial perfusion in children with Kawasaki disease without angiographic evidence of coronary stenosis using positron emission tomography and H2(15)O. Coron. Artery Dis.6(7), 555–559 (1995).
   PubMed Web of Science ®Google Scholar
• Ikemoto Y. Nitric oxide in Kawasaki disease. J. Pediatr.142(5), 594–595; author reply 595–596 (2003).
   PubMedGoogle Scholar
• Adewuya O, Irie Y, Bian K, Onigu-Otite E, Murad F. Mechanism of vasculitis and aneurysms in Kawasaki disease: role of nitric oxide. Nitric Oxide8(1), 15–25 (2003).
   PubMed Web of Science ®Google Scholar
• Khajoee V, Kariyazono H, Ohno T et al. Inducible and endothelial constitutive nitric oxide synthase gene polymorphisms in Kawasaki disease. Pediatr. Int.45(2), 130–134 (2003).
   PubMed Web of Science ®Google Scholar
• Suzuki A, Miyagawa-Tomita S, Komatsu K et al. Active remodeling of the coronary arterial lesions in the late phase of Kawasaki disease: immunohistochemical study. Circulation101(25), 2935–2941 (2000).
   PubMed Web of Science ®Google Scholar
• Okubo M, Ino T, Takahashi K et al. Age dependency of stiffness of the abdominal aorta and the mechanical properties of the aorta in Kawasaki disease in children. Pediatr. Cardiol.22(3), 198–203 (2001).
   PubMed Web of Science ®Google Scholar
• Tsuda E, Kamiya T, Ono Y, Kimura K, Echigo S. Dilated coronary arterial lesions in the late period after Kawasaki disease. Heart91(2), 177–182 (2005).
   PubMed Web of Science ®Google Scholar
• Kato H, Ichinose E, Yoshioka F et al. Fate of coronary aneurysms in Kawasaki disease: serial coronary angiography and long-term follow-up study. Am. J. Cardiol.49(7), 1758–1766 (1982).
   PubMed Web of Science ®Google Scholar
• Newburger JW. Kawasaki Disease. Curr. Treat. Options Cardiovasc. Med.2(3), 227–236 (2000).
   PubMedGoogle Scholar
• Kato H, Sugimura T, Akagi T et al. Long-term consequences of Kawasaki disease. A 10- to 21-year follow-up study of 594 patients. Circulation94(6), 1379–1385 (1996).
   PubMed Web of Science ®Google Scholar
• Kato H, Inoue O, Kawasaki T et al. Adult coronary artery disease probably due to childhood Kawasaki disease. Lancet340(8828), 1127–1129 (1992).
   PubMed Web of Science ®Google Scholar
• Miyagawa M, Mochizuki T, Murase K et al. Prognostic value of dipyridamole-thallium myocardial scintigraphy in patients with Kawasaki disease. Circulation98(10), 990–996 (1998).
   PubMed Web of Science ®Google Scholar
• Iemura M, Ishii M, Sugimura T, Akagi T, Kato H. Long term consequences of regressed coronary aneurysms after Kawasaki disease: vascular wall morphology and function. Heart83(3), 307–311 (2000).
   PubMed Web of Science ®Google Scholar
• Zilberman MV, Goya G, Witt SA, Glascock B, Kimball TR. Dobutamine stress echocardiography in the evaluation of young patients with Kawasaki disease. Pediatr. Cardiol.24(4), 338–343 (2003).
   PubMed Web of Science ®Google Scholar
• Hauser M, Bengel F, Kuehn A et al. Myocardial blood flow and coronary flow reserve in children with ‘normal’ epicardial coronary arteries after the onset of Kawasaki disease assessed by positron emission tomography. Pediatr. Cardiol.25(2), 108–112 (2004).
   PubMed Web of Science ®Google Scholar
• Furuyama H, Odagawa Y, Katoh C et al. Assessment of coronary function in children with a history of Kawasaki disease using (15)O-water positron emission tomography. Circulation105(24), 2878–2884 (2002).
   PubMed Web of Science ®Google Scholar
• Furuyama H, Odagawa Y, Katoh C et al. Altered myocardial flow reserve and endothelial function late after Kawasaki disease. J. Pediatr.142(2), 149–154 (2003).
   PubMed Web of Science ®Google Scholar
• Sato Y, Kato M, Inoue F et al. Detection of coronary artery aneurysms, stenoses and occlusions by multislice spiral computed tomography in adolescents with Kawasaki disease. Circ. J.67(5), 427–430 (2003).
   PubMed Web of Science ®Google Scholar
• Fukuda T, Ishibashi M, Yokoyama T et al. Myocardial ischemia in Kawasaki disease: evaluation with dipyridamole stress technetium 99m tetrofosmin scintigraphy. J. Nucl. Cardiol.9(6), 632–637 (2002).
   PubMed Web of Science ®Google Scholar
• Fu YC, Liu FY, Tsai SC, Hwang B, Chi CS. Poor agreement between dipyridamole-stress technetium-99m-tetrofosmin myocardial perfusion single photon emission computed tomography and two-dimensional echocardiography in Kawasaki disease. Int. J. Cardiol.90(1), 57–61 (2003).
   PubMed Web of Science ®Google Scholar
• Hiraishi S, Hirota H, Horiguchi Y et al. Transthoracic Doppler assessment of coronary flow velocity reserve in children with Kawasaki disease: comparison with coronary angiography and thallium-201 imaging. J. Am. Coll. Cardiol.40(10), 1816–1824 (2002).
   PubMed Web of Science ®Google Scholar
• Noto N, Karasawa K, Kanamaru H et al. Non-invasive measurement of coronary flow reserve in children with Kawasaki disease. Heart87(6), 559–565 (2002).
   PubMed Web of Science ®Google Scholar
• Harada K, Yasuoka K, Tamura M, Toyono M. Coronary flow reserve assessment by Doppler echocardiography in children with and without congenital heart defect: comparison with invasive technique. J. Am. Soc. Echocardiogr.15(10 Pt 2), 1121–1126 (2002).
   PubMed Web of Science ®Google Scholar
• Mavrogeni S, Papadopoulos G, Douskou M et al. Magnetic resonance angiography is equivalent to x-ray coronary angiography for the evaluation of coronary arteries in Kawasaki disease. J. Am. Coll. Cardiol.43(4), 649–652 (2004).
   PubMed Web of Science ®Google Scholar
• Greil GF, Stuber M, Botnar RM et al. Coronary magnetic resonance angiography in adolescents and young adults with Kawasaki disease. Circulation105(8), 908–911 (2002).
   PubMed Web of Science ®Google Scholar
• Danias PG, Stuber M, Botnar RM et al. Coronary MR angiography clinical applications and potential for imaging coronary artery disease. Magn. Reson. Imaging Clin. N. Am.11(1), 81–99 (2003).
   PubMedGoogle Scholar
• Mavrogeni S, Papadopoulos G, Douskou M et al. Magnetic resonance angiography, function and viability evaluation in patients with Kawasaki disease. J. Cardiovasc. Magn. Reson.8, 493–498 (2006).
   PubMed Web of Science ®Google Scholar
• Schratz LM, Meyer RA, Schwartz DC. Serial intracoronary ultrasound in children: feasibility, reproducibility, limitations, and safety. J. Am. Soc. Echocardiogr.15(8), 782–790 (2002).
   PubMed Web of Science ®Google Scholar
• Dahdah NS, Jaeggi E, Fournier A. Electrocardiographic depolarization and repolarization: long-term after Kawasaki disease. Pediatr. Cardiol.23(5), 513–517 (2002).
   PubMed Web of Science ®Google Scholar
• Murakami H, Hirokami M, Hanawa N et al. Acetylcholine-induced coronary spasm with a history of Kawasaki disease: case report. Circ. J.67(3), 273–274 (2003).
   PubMed Web of Science ®Google Scholar
• Onouchi Z, Hamaoka K, Sakata K et al. Long-term changes in coronary artery aneurysms in patients with Kawasaki disease: comparison of therapeutic regimens. Circ. J.69(3), 265–272 (2005).
   PubMed Web of Science ®Google Scholar
• Levy DM, Silverman ED, Massicotte MP, McCrindle BW, Yeung RS. Longterm outcomes in patients with giant aneurysms secondary to Kawasaki disease. J. Rheumatol.32(5), 928–934 (2005).
   PubMed Web of Science ®Google Scholar
• Ishii M, Ueno T, Ikeda H et al. Sequential follow-up results of catheter intervention for coronary artery lesions after Kawasaki disease: quantitative coronary artery angiography and intravascular ultrasound imaging study. Circulation105(25), 3004–3010 (2002).
   PubMed Web of Science ®Google Scholar
• Yamauchi H, Ochi M, Fujii M et al. Optimal time of surgical treatment for Kawasaki coronary artery disease. J. Nippon. Med. Sch.71(4), 279–286 (2004).
   PubMedGoogle Scholar
• Furukawa S, Matsubara T, Umezawa Y et al. Pentoxifylline and intravenous γ globulin combination therapy for acute Kawasaki disease. Eur. J. Pediatr.153(9), 663–667 (1994).
   PubMed Web of Science ®Google Scholar
• Shen CT, Wang NK. Antioxidants may mitigate the deterioration of coronary arteritis in patients with Kawasaki disease unresponsive to high-dose intravenous γ-globulin. Pediatr. Cardiol.22(5), 419–422 (2001).
   PubMed Web of Science ®Google Scholar
• Zaitsu M, Hamasaki Y, Tashiro K et al. Ulinastatin, an elastase inhibitor, inhibits the increased mRNA expression of prostaglandin H2 synthase-type 2 in Kawasaki disease. J. Infect. Dis.181(3), 1101–1109 (2000).
   PubMed Web of Science ®Google Scholar